261 filings
Page 10 of 14
8-K
jagmdassa0
23 Feb 17
Sage Therapeutics Announces Fourth Quarter and Full Year 2016 Financial
12:00am
S-8
5kge4anirunm7
23 Feb 17
Registration of securities for employees
12:00am
8-K
kvawsfuf
3 Nov 16
Sage Therapeutics Announces Third Quarter 2016 Financial Results and Provides
12:00am
8-K
vko083
15 Sep 16
Other Events
12:00am
424B5
bzak5si5ntyh26n
9 Sep 16
Prospectus supplement for primary offering
12:00am
8-K
7586bef ctfptz
9 Sep 16
Sage Therapeutics Announces Proposed Public Offering of Common Stock
12:00am
424B5
i2a 94oh17er
7 Sep 16
Prospectus supplement for primary offering
12:00am
UPLOAD
qcra wksfunu9
23 Aug 16
Letter from SEC
12:00am
CORRESP
jnyhs
16 Aug 16
Correspondence with SEC
12:00am
8-K
fn3vdj
9 Aug 16
Sage Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
12:00am
UPLOAD
q7sozen1ml0 071u2s6
26 Jul 16
Letter from SEC
12:00am
8-K
r2gxzu 4c9f
21 Jul 16
Sage Appoints Geno Germano to Company’s Board of Directors
12:00am
8-K
ewf bu8abh35wb6balyu
13 Jul 16
Sage Reports Positive Top-line Results Including Demonstration of 30-Day Durability from
12:00am
8-K
0cfi41 iarsbii
23 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
bxjpgv3
31 May 16
Entry into a Material Definitive Agreement
12:00am
8-K
e4piwe
3 May 16
Departure of Directors or Certain Officers
12:00am
DEFA14A
6eq7c
29 Apr 16
Additional proxy soliciting materials
12:00am